How does one tell DCT companies apart? Great post from Kate Flathers, our Head of Product, tackling this important question. Short spoiler: it's about moving beyond DCT and addressing patient-centricity. bit.ly/3W9t0WC #dct #clinicalresearch

If you're not already subscribed to the Before We Die podcast, tune in on December 27 to catch Hawthorne Effect Founder + CEO Jodi Akin talk about democratization of clinical research in a post-pandemic world: bit.ly/3hxWzTb #clinicaltrials #patientcentricity

If you're not already subscribed to the Before We Die podcast, tune in on December 27 to catch Hawthorne Effect Founder + CEO Jodi Akin talk about democratization of clinical research in a post-pandemic world: bit.ly/3hxWzTb #clinicaltrials #patiententricity

Elevation of #clinicaltrials in consumer care and a revolution in site models point the way forward in clinical research, says Hawthorne Effect Founder + CEO Jodi Akin. It's time to go beyond #decentralizedtrials. bit.ly/3j5rxSQ

Elevation of #clinicaltrials in consumer care and a revolution in site models point the way forward for deliberate change in clinical research, says Hawthorne Effect Founder + CEO Jodi Akin. It's time to move beyond #decentralizedtrials. bit.ly/3j5rxSQ

Is anyone attending the 2023 SCOPE Summit (2/6-2/9) in Orlando? Hawthorne Effect Founder + CEO Jodi Akin is co-chairing the Venture, Innovation, & Partnering Conference on 2/7 that brings together innovation and investment in #clinicaltrials. #scopesummit bit.ly/3w87uqc

Diversity in #clinicaltrials is important, and more remains to be done for inclusivity. But what are the implications when we consider specific research areas like cardiovascular? Heart disease is still our #1 killer, so we're digging into it. bit.ly/3XqHKkW

Tech is only one part of aligning #clinicalresearch and consumer healthcare - a solution still requires people. HE's Jodi Akin will elaborate on this as co-chair of the SCOPE Venture, Innovation & Partnering Conference, but here's a preview: bit.ly/3jbYFJe #scopesummit

"History teaches us that disruptive market transformations take 10 years on average ... I believe that we are around the 7-year moment of that transformation arc" says Jodi Akin re: democratization of #clinicaltrials. More to come from #scopesummit. bit.ly/3jLdClw

Great #scopesummit panel on bridging the chasm of research and care. We touched on this very subject not long ago: bit.ly/3jbYFJe. #clinicaltrials #dct

So exciting to see Hawthorne Effect Founder + CEO Jodi Akin live at #scopesummit! #clinicaltrials

Third day of #SCOPE2023! Yesterday's Venture, Innovation, & Partnering Conference was amazing, and there are still so many great panels to come. #scopesummit #patientaccess

If you're headed to New Orleans next weekend for #ACC2023, make sure to stop by Booth 410 and say hello to the Hawthorne Effect team! We're excited to talk about #clinicaltrials at one of the best gatherings for cardiologists and heart specialists. bit.ly/3XZLppa

Hawthorne Heroes get to participate in world-class research by bringing clinical trials directly to patients, and that often results in incredible stories. Here's Hero Julie Dunn talking about one of her favorite #clinicaltrials experiences. bit.ly/3Zx5G6I

Day two of #acc23! Great crowds and conversations yesterday.

We're happy to celebrate International Women's Day and #EmbraceEquity. Our Founder + CEO Jodi Akin started Hawthorne Effect in large part to increase diversity in #clinicaltrials, and equity and diversity are critical to all of #clinicalresearch and healthcare.

On #clinicaltrialsday, we want to celebrate and give thanks to the amazing healthcare pros, sponsors, and patients who make #clinicalresearch happen. Moreover, we want to say it loud and clear: the impact of your work is immediate and unmistakable. bit.ly/41T05by

Thanks to Foley & Lardner LLP for hosting Jodi on the Health Care Law Today Podcast! bit.ly/3NwvGw7

forbes.com/sites/stevenaq… We're very thankful to Steven Aquino (he/him) and Forbes for their highlight of our Founder + CEO Jodi Akin, not to mention Hawthorne's efforts to make clinical trials available to all!

Our partnership with CRF is changing the industry standard for inclusiveness in clinical trials! Thank you to Outsourcing-Pharma & Liza Laws for highlighting the new bar the Prevue-Valve study is setting for diverse patient recruitment. bit.ly/3ZQcnCn